Bend Research and Catalent Pharma Solutions have entered into an agreement to provide integrated solutions for pharma companies seeking to develop and manufacture specialized multiparticulate oral controlled-release products. The companies will provide an integrated approach to bring complex CR products to market faster and more efficiently with optimal therapeutic and release profiles. According to a joint statement, “The companies’ combined expertise in formulation development and Catal...